Tower Research Capital (TRC)’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,768
| Closed | -$3K | – | 6857 |
|
|
2022
Q3 | $3K | Sell |
11,768
-10,328
| -47% | -$2.63K | ﹤0.01% | 5502 |
|
|
2022
Q2 | $8K | Buy |
22,096
+9,535
| +76% | +$3.45K | ﹤0.01% | 4743 |
|
|
2022
Q1 | $8K | Buy |
12,561
+9,547
| +317% | +$6.08K | ﹤0.01% | 4659 |
|
|
2021
Q4 | $7K | Buy |
3,014
+1,869
| +163% | +$4.34K | ﹤0.01% | 4990 |
|
|
2021
Q3 | $5K | Sell |
1,145
-2,465
| -68% | -$10.8K | ﹤0.01% | 4925 |
|
|
2021
Q2 | $16K | Buy |
3,610
+467
| +15% | +$2.07K | ﹤0.01% | 4101 |
|
|
2021
Q1 | $23K | Buy |
3,143
+1,207
| +62% | +$8.83K | ﹤0.01% | 3790 |
|
|
2020
Q4 | $15K | Sell |
1,936
-9,977
| -84% | -$77.3K | ﹤0.01% | 4074 |
|
|
2020
Q3 | $108K | Buy |
11,913
+9,930
| +501% | +$90K | ﹤0.01% | 3100 |
|
|
2020
Q2 | $17K | Sell |
1,983
-266
| -12% | -$2.28K | ﹤0.01% | 3774 |
|
|
2020
Q1 | $11K | Buy |
+2,249
| New | +$11K | ﹤0.01% | 1999 |
|
|
2019
Q3 | – | Sell |
-1,523
| Closed | -$20K | – | 4682 |
|
|
2019
Q2 | $20K | Buy |
1,523
+914
| +150% | +$12K | ﹤0.01% | 2193 |
|
|
2019
Q1 | $6K | Buy |
+609
| New | +$6K | ﹤0.01% | 2996 |
|